288
Participants
Start Date
August 31, 2004
Primary Completion Date
January 31, 2007
Study Completion Date
January 31, 2007
MR Prednisone
Participants will receive tablets containing MR prednisone (to achieve the appropriate dose of 3-10 milligrams \[mg\] prednisone per day) at bed time.
IR Prednisone
Participants will receive tablets containing IR prednisone (to achieve the appropriate dose of 3-10 mg prednisone per day) in the morning.
Placebo - MR Prednisone
Participants will receive placebo matching to MR prednisone tablet at bed time.
Placebo - IR Prednisone
Participants will receive placebo matching to IR prednisone tablet in the morning.
Research Site, Aachen
Research Site, Bad Kreuznach
Research Site, Berlin
Research Site, Cologne
Research Site, Dresden
Research Site, Düsseldorf
Research Site, Erlangen
Research Site, Frankfurt am Main
Research Site, Hamburg
Research Site, Hanover
Research Site, Jena
Research Site, Leipzig
Research Site, München
Research Site, Ratingen
Research Site, Rostock
Research Site, Bialystok
Research Site, Katowice
Research Site, Krakow
Research Site, Lublin
Research Site, Poznan
Research Site, Sopot
Research Site, Torun
Research Site, Warsaw
Research Site, Wroclaw
Merck KGaA, Darmstadt, Germany
INDUSTRY